Skip to main content
Erschienen in: European Journal of Pediatrics 4/2018

31.01.2018 | Original Article

Knowledge of allergies and performance in epinephrine auto-injector use: a controlled intervention in preschool teachers

verfasst von: Henriette Karoline Dumeier, Luca Anne Richter, Martina Patrizia Neininger, Freerk Prenzel, Wieland Kiess, Astrid Bertsche, Thilo Bertsche

Erschienen in: European Journal of Pediatrics | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Epinephrine auto-injectors are used for first aid in anaphylactic emergencies by non-healthcare professionals, e.g., (pre-)school teachers. We developed an education session for preschool teachers addressing allergies, anaphylactic emergencies, and administering auto-injectors. We assessed their attitudes and knowledge in allergies and anaphylactic emergency by a questionnaire and monitored their practical performance in administering auto-injectors before the education session, directly after, and 4–12 weeks after the session. From 75 teachers giving their consent to participate, 81% had children with allergies under their supervision and 3% had already administered medication from an available rescue kit. The knowledge of triggers of allergies increased from 9 to 55% directly and to 33% 4–12 weeks after the session (both p < 0.001, compared to baseline). Directly after the session, the number of teachers who felt well-prepared for an anaphylactic emergency rose from 11 to 88%, which decreased to 79% 4–12 weeks thereafter (each p < 0.001). The number of auto-injector administrations without any drug-related problems increased from 3 to 35% directly after the session and shrunk to 16% 4–12 weeks afterwards (both p < 0.025).
Conclusion: A single education session substantially improved preschool teachers’ attitudes and knowledge in allergies and anaphylactic emergencies. Additionally, their practical performance in auto-injector administration increased.
What is Known:
Food allergies are increasing among children.
The knowledge about allergies and anaphylactic emergencies is poor.
What is New:
The proportion of teachers who felt well-prepared for an anaphylactic emergency increased after a single education session.
The proportion of auto-injector administrations without any drug-related problems additionally increased due to an education session.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Dumeier HK, Neininger MP, Bernhard MK, Merkenschlager A, Kiess W, Bertsche T, Bertsche A (2017) Providing teachers with education on epilepsy increased their willingness to handle acute seizures in children from 1-10 years of age. Acta Paediatr 106(11):1811–1816. https://doi.org/10.1111/apa.13938 CrossRefPubMed Dumeier HK, Neininger MP, Bernhard MK, Merkenschlager A, Kiess W, Bertsche T, Bertsche A (2017) Providing teachers with education on epilepsy increased their willingness to handle acute seizures in children from 1-10 years of age. Acta Paediatr 106(11):1811–1816. https://​doi.​org/​10.​1111/​apa.​13938 CrossRefPubMed
6.
Zurück zum Zitat Foster AA, Campbell RL, Lee S, Anderson JL (2015) Anaphylaxis preparedness among preschool staff before and after an educational intervention. J Allergy 2015:231862CrossRef Foster AA, Campbell RL, Lee S, Anderson JL (2015) Anaphylaxis preparedness among preschool staff before and after an educational intervention. J Allergy 2015:231862CrossRef
7.
Zurück zum Zitat Gold MS, Sainsbury R (2000) First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allerg Clin Immunol 106:171–176CrossRef Gold MS, Sainsbury R (2000) First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allerg Clin Immunol 106:171–176CrossRef
8.
Zurück zum Zitat Grabenhenrich LB, Dolle S, Moneret-Vautrin A, Kohli A, Lange L, Spindler T, Rueff F, Nemat K, Maris I, Roumpedaki E et al (2016) Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allerg Clin Immunol 137:1128–1137CrossRef Grabenhenrich LB, Dolle S, Moneret-Vautrin A, Kohli A, Lange L, Spindler T, Rueff F, Nemat K, Maris I, Roumpedaki E et al (2016) Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allerg Clin Immunol 137:1128–1137CrossRef
9.
Zurück zum Zitat Kaune A, Schumacher PM, Hoppe SC, Syrbe S, Bernhard MK, Frontini R, Merkenschlager A, Kiess W, Neininger MP, Bertsche A, Bertsche T (2013) Administration of anticonvulsive rescue medication in children—discrepancies between parents’ self-reports and limited practical performance. Eur J Pediatr 175:1139–1146CrossRef Kaune A, Schumacher PM, Hoppe SC, Syrbe S, Bernhard MK, Frontini R, Merkenschlager A, Kiess W, Neininger MP, Bertsche A, Bertsche T (2013) Administration of anticonvulsive rescue medication in children—discrepancies between parents’ self-reports and limited practical performance. Eur J Pediatr 175:1139–1146CrossRef
11.
17.
Zurück zum Zitat Ring J, Beyer K, Dorsch A, Biedermann T, Fischer J, Friedrichs F, Gebert N, Gieler U, Grosber M, Jakob T et al (2014) Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB). Allergo J Int 23:96–112CrossRefPubMedPubMedCentral Ring J, Beyer K, Dorsch A, Biedermann T, Fischer J, Friedrichs F, Gebert N, Gieler U, Grosber M, Jakob T et al (2014) Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB). Allergo J Int 23:96–112CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Sicherer SH, Forman JA, Noone SA (2000) Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 105(2):359–362CrossRefPubMed Sicherer SH, Forman JA, Noone SA (2000) Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 105(2):359–362CrossRefPubMed
21.
Zurück zum Zitat Simons FER, Edwards ES, Read EJ, Clark S, Liebelt EL (2010) Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allerg Clin Immunol 125:419–423CrossRef Simons FER, Edwards ES, Read EJ, Clark S, Liebelt EL (2010) Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allerg Clin Immunol 125:419–423CrossRef
22.
Zurück zum Zitat Simons FER, Ardusso LF, Bilo MB, Cardona V, Ebisawa M, El-Gamal YM, Lieberman P, Lockey RF, Muraro A, Roberts G et al (2014) International consensus on (ICON) anaphylaxis. World Allergy Organ J 7:9CrossRefPubMedPubMedCentral Simons FER, Ardusso LF, Bilo MB, Cardona V, Ebisawa M, El-Gamal YM, Lieberman P, Lockey RF, Muraro A, Roberts G et al (2014) International consensus on (ICON) anaphylaxis. World Allergy Organ J 7:9CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Umasunthar T, Procktor A, Hodes M, Smith JG, Gore C, Cox HE, Marrs T, Hanna H, Phillips K, Pinto C et al (2017) Patients’ ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial. Allergy 70:855–863CrossRef Umasunthar T, Procktor A, Hodes M, Smith JG, Gore C, Cox HE, Marrs T, Hanna H, Phillips K, Pinto C et al (2017) Patients’ ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial. Allergy 70:855–863CrossRef
Metadaten
Titel
Knowledge of allergies and performance in epinephrine auto-injector use: a controlled intervention in preschool teachers
verfasst von
Henriette Karoline Dumeier
Luca Anne Richter
Martina Patrizia Neininger
Freerk Prenzel
Wieland Kiess
Astrid Bertsche
Thilo Bertsche
Publikationsdatum
31.01.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 4/2018
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-017-3073-y

Weitere Artikel der Ausgabe 4/2018

European Journal of Pediatrics 4/2018 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.